Vaccines

Pfizer, Inc. (NYSE:PFE) shares moved higher on Wednesday. The sector has seen volatility amid Robert F. Kennedy Jr.’s nomination as the secretary of the Department of Health and Human Services. The Details: According to NBC, the Senate Finance Committee voted 14-13 along party lines to pass...

The U.S. reported its first human death from the H5 bird flu strain this week, causing a spike in vaccine developer stocks Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), CureVac (NASDAQ:CVAC) and Pfizer (NYSE:PFE). Vaccine production efforts are ramping up as health officials monitor the outbreak...

The U.S. stock market experienced a downturn on Tuesday, with the Nasdaq Composite falling by 1.9% and the S&P 500 dropping by 1.1%. The Dow Jones Industrial Average also declined by 0.4%. These are the top stocks that gained the attention of retail traders and investors throughout the day:...

Avian flu has continued to make headlines as cases extend beyond cattle and poultry; the flu has now affected cats and possibly horses. The flu has begun to affect the American consumer as egg prices soar. The Latest On Bird Flu: A recent research study from the University of Glasgow found the...

Bird flu has been detected in a batch of raw milk sold in California and a voluntary recall of the milk has been issued at the request of the state's department of public health.  The Details: The virus was found during testing of a batch of whole raw milk from Raw Farm in Fresno county. The...

A child in Alameda County, California is the latest case of bird flu in the U.S. According to the Los Angeles Times, the total case count in the U.S. stands at 54. Thirty-one cases are attributed to the dairy industry and 21 to the poultry industry. Two of the case’s causes are unknown....

President-elect Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda. Trading in pharmaceutical stocks is shaky this week and the details are few surrounding a possible appointment. What To Know:...

The World Health Organization announced a new strategic preparedness and response plan Monday in the fight against mpox, two weeks after declaring a public health emergency on the outbreak. What Happened: The WHO announced a new plan in its fight against the outbreak of mpox. The plan comes as...

Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) submitted clinical data on Thursday to the European Medicines Agency (EMA) to support the extension of the Imvanex (MVA-BN) smallpox and mpox vaccine indication to include adolescents 12 to 17 years of age. Jynneos is known internationally as...

The World Health Organization issued an international public health emergency Wednesday over mpox, leading to increased concern around travel to Africa and causing mpox stocks to trade higher once again. What Happened: A rise in mpox cases in Africa prompted the WHO to issue a public health...

AstraZeneca Plc (NASDAQ:AZN) is reportedly reconsidering its planned $578.4 million (450 million pounds) investment in a new vaccine-manufacturing site, a departure from CEO Pascal Soriot‘s previous statement that the company was “absolutely ready to go.” What Happened: The UK...

Vaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting people around the globe. On Thursday, a 59-year-old man with previous health conditions died in Mexico after contracting the H5N2 virus. The source of the virus in this case remains unknown. The...

Surprisingly, it is not Big Tech that kicked off 2024 but healtchare champions. Moderna Inc (NASDAQ: MRNA) shares rose after Oppenheimer upgraded the stock due to the Covid-19 vaccine star possibly marketing as many as five products by 2026. Merck & CO Inc (NYSE: MRK) shares also...

The U.S. Food and Drug Administration (FDA) identified several quality control issues at the primary manufacturing facility of Moderna Inc. (NASDAQ: MRNA) during a September inspection.  This revelation comes from a report obtained through a Freedom of Information Act request,...

Key Takeaways: Flush with funds from its backers, Stemirna built manufacturing plants that were able to produce up to 400 million vaccine doses a year and put together a sales force for an anticipated surge in Covid demand But after the pandemic opportunities have faded, Stemirna is rebranding...